DIRECTOR AGREEMENTDirector Agreement • March 28th, 2018 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledMarch 28th, 2018 Company Industry JurisdictionThis DIRECTOR AGREEMENT is made as of June 23, 2016 (the “Agreement”), by and between Osiris Therapeutics, Inc., a Maryland corporation (the “Company”), and Thomas M. Brandt, Jr. (the “Director”).
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • March 28th, 2018 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledMarch 28th, 2018 Company Industry JurisdictionOsiris Therapeutics, Inc. (“Osiris” or the “Company”) and Linda Palczuk (“You”) enter into this Separation and Release Agreement (“Agreement”) effective as of the Effective Date (as defined below).